Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Please submit your application as soon as possible, as we reserve the right to close this advertisement at any time. Cochlear’s mission is to help people hear and be heard. As the global leader in implantable hearing
With around 2100 Bachelors and Masters students, the Zurich University of the Arts (ZHdK) is one of the largest and most diverse art academies in Europe. The fields of study and research include art education, design,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Position Transaction Manager / Senior Transaction Manager Department & Team Transaction Management Office (TMO) – Borrowing Base Desk Location Geneva - Switzerland Role Purpose Within ING’s TCF franchise, the Borrowing Base Desk supports complex structured trade
Junior Recruiter / HR Generalist starting date asap / duration 4-5 months Coppet Fixed-Term Full-time Introduction Unilabs is the largest provider of medical laboratory diagnostics for prescribers and hospitals in Switzerland and employs around 800 people.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
What we are looking for: Were seeking an experienced Hub Engagement Manager to join NRC Switzerland on a 50% basis. This is an exciting opportunity for an energetic, highly organised and relationship-focused professional who thrives at
Company Description Die MF Group ist eine Tochtergesellschaft von Riverty und Teil des weltweit tätigen Bertelsmann-Konzerns und beschäftigt rund 100 Mitarbeitende an zwei Standorten in der Schweiz. Sie ist der führende Schweizer Anbieter für Kauf auf
Company Description MF Group is a subsidiary of Riverty and part of the Bertelsmann Group. Around 120 employees work across two locations in Switzerland to make invoice-based purchasing with flexible installment payments even simpler and safer
Company Description MF Group is a subsidiary of Riverty and part of the Bertelsmann Group. Around 120 employees work across two locations in Switzerland to make invoice-based purchasing with flexible installment payments even simpler and safer
Company Description MF Group is a subsidiary of Riverty and part of the Bertelsmann Group. Around 120 employees work across two locations in Switzerland to make invoice-based purchasing with flexible installment payments even simpler and safer
Do you want to dive in the fast-growing industry of drones and get a rewarding experience in a dynamic scale-up environment? At Flyability, we believe that robots should be sent into hazardous places and dangerous environments